Edward Fitzgerald
Vermögen: 402 011 $ am 30.06.2026
Vermögen: 402 011 $ am 30.06.2026
Edward M.
Fitzgerald is an Independent Director at Parabilis Medicines, Inc. since 2017.
Formerly, Mr. Fitzgerald was an Independent Director at Akcea Therapeutics, Inc. from 2017 to 2020.
Served as Chief Financial Officer, Treasurer, and Executive Vice President at ARIAD Pharmaceuticals, Inc. from 2011 to 2016.
Held the roles of Chief Financial Officer, Secretary, and Senior Vice President at AltaRex Medical Corp.
from 1998 to 2002.
Worked as a Partner at Arthur Andersen LLP from 1989 to 1992.
Served as a Trustee at Babson College from 1997 to 2006.
Education includes undergraduate and MBA degrees from Babson College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 14’688 ( 0.01% ) | 402 011 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PARABILIS MEDICINES, INC. | Direktor/Vorstandsmitglied | 01.07.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2020 |
| ARIAD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 21.03.2016 |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.01.2006 |
AltaRex Medical Corp.
AltaRex Medical Corp. Miscellaneous Commercial ServicesCommercial Services Develops and research foreign antibodies for cancer and life-threatening disease treatment | Finanzdirektor/CFO | 01.04.2002 |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01.01.1992 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
AltaRex Medical Corp.
AltaRex Medical Corp. Miscellaneous Commercial ServicesCommercial Services Develops and research foreign antibodies for cancer and life-threatening disease treatment | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Parabilis Medicines
Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen